Member Info for Jacobjohn7

Yes it will be blue by eod

Need another deal and revenue to bother 2p level however.

But should get steady buying over the week. Who knows may get more news

Wonder where dyor is . And his reincarnation ?

This is also a great shelter from the negative turbulence of the main market...

One more deal here were off to the races.

We're getting the infrastructure in, we need to populate it now..

Duke and iowa will at least be through when the new budgets are renewed.

The sensible investor, hopefully buys low, and also assesses is there traction..

I got out high. I get in low. I'm impressed with newflow Michael the bad investor and narcissist...

You have to react to how a company gains traction michael. Maybe it's a bit too fast for your dull mind Mike?

We do need deals and revenues however. But I'm impressed with 2025 polarean.

News and revenues will follow.

I advise you to top up Mike... but oh no. You didn't sell any high so are still nursing losses.

Bless.

Home - Shangju Industrial Co., Ltd. https://search.app/mBqYQVZH8mcwXPBT9

...based on future revenue % for them. But wonder if any form of payment from the Taiwanese co. To polarean to take on the rights to sell into the Taiwanese market?

No revenue mentioned again

Not sure whether mutual

Maybe 2025 is the transformative year for polarean. It's quite a contrast to the 6 months of nothing in 2024!

Keep up the good work cvj. You ain't been slacking my bad.

This turbo.

Hui-Lin Su, General Manager of Sumtage, said: 'We are excited to work with Polarean to bring this groundbreaking Xenon MRI technology to Taiwan to help address lung diseases such as lung cancer, COPD, and asthma. The Polarean Xenon MRI platform enables advanced lung function assessments, allowing physicians to identify affected regions at earlier stages and facilitate timely treatment. We have already seen strong interest from leading academic medical centers, highlighting the significant potential of this technology to improve lung health in Taiwan."

 

Added on top of a good chunk last week.

Sales guys can keep ploughing the u.s whilst the Taiwan and far east play out.

A sale will make me feel a tad more reassured however.

The Taiwan ceo says already got strong institutional interest. Sounds good once permits been received

We have to see something that's keeping the wolves from the door also soon I feel. These agreements are fine when combined with sales agreements... I don't fancy getting diluted (again)

They've been busy cvj haven't just been thinking about the next gala luncheon.

Well done them and well done patient holders.

Optimism proving right... would like to see if it's worth anything to the bottom line again.

But no one can now fault the recent progress.

Will probably add today glad I picked up a decent portion cheap on Friday.

Every morning scary when not in polarean this current year.

It could be the year of the lung.

Gla.

I don't care about filtering, as I've said before there's more than one negative and more the assorted group who post here who see this.

If there anything In the background with the China thing then great. If.

Just quit the anyone else turns up whose negative and more abusive, it ain't me.

The abuse levels on multiple share forums that others do, probably did end in ejection .. or he had done his job and just closed the account. I don't get that.

You have a nice day

I hope this ckesrs a few things up. I'm happy to see people positive about something they don't get much reason to be... just don't be too blinkered.

I never short its a despicable practice in my view, I've always been vociferous against it.

In fact I'd rund the feckers up and shoot em.

They're destroying the uk stock market, their control and affect is out of scale leverage compared to the majority long holders. There's something fundamentally wrong there with the system, and it destroys holds back good companies.

Polarean only need cvj's pace to do that.

I'm merely responding to the group hatred presented here to anyone who says there's not enough commercial traction here.

We are close to the 9th month. 3/4 of a year since a deal that we haven't heard anymore of since. That's a long time considering the cash runway,. They can't do one deal a year and dilute every and expect to exist. Cvj and co will be happy taking their well provided for renumeration.

Don't present hatred you won't get any back.

I'm here as I want to be convinced... and I expect that the speed of these guys there might be some really cheap shares at some point.

As the cash burn will have been vastly increased when figures announced and the last two items in fact appear to have cost the company initially.

Rather than increased sales.

Jusr accept another view if they add another deal current year and steady flow one a month almost which is their forecast in 2025 then I'd be happy enough with traction to invest.

As I did Like the company to obsession at one stage, I don't like the treatment of the shareholders, fine and you won't understand if your first foray was picking up 1p shares.

Regards

Because as a measure of weakness of the price and background seller you can sell below the mid in which case the bid offer should be 1.2 - 1 25 with a mid of 1.225 which means a tick down as that's where the market is in reality

Apologies for typos this app is a big sack o wa nk

Napalm I'm the worst investor, I avoid the fall i forecast here... you dint. I invest elsewhere incessant my funds.

You see yours deteriorating daily. Even this rampef fantastic news does less than zero..

But I'm the bad investor yoo funny

Courtesy goldbutler on advfn.

A prefect summary and some of you need to remember the treatment of rank and file shareholders at polx...

"This ,current,CEO Dr Von Jacko and Board of Directors all highly paid in cash, bonuses and options has the sheer effrontery to use words in relation to the China patent such as

" in our mission to optimise lung health globally.....when the time is right,".

3 years after applying for FDA approval and almost 6 million in cash and options for Von Jacko and the Board of Directors .. together with a fund raise which lasted almost 18 months - which he "discussed" with Bracco and Nukem and allowed them to take almost 35% of the company.

When you consider the price and amounts subscribed for by Amati and other UK fund managers - in earlier funding together with Brokers sales and revenue figures - it is not difficult to see the utter failure to move the share price.

When is "when the time is right,." for this CEO to address shareholders and update the market

on the first de novo sale - previously announced

or the results for year to December 2024

or the Application to FDA -forecast to be in the last quarter of 2024

or the long covid study in the UK

There are those on the other board claiming that commercial traction isn't all about

Sales and Revenue -

Have a look at the share price and share price graph and director share buying versus directors fees and salaries and options. And the 1.2 billion shares in issue.

Shareholders on AIM are the last thing on this CEO von Jacko's mind

this is all about him - and his directors and Bracco and Nukem

The market obviously don't like China... maybe they see it as spreading too thin on limited funds and timescale left.

News has happened none have the magical word revenue attached to them.

No one going to buy here for their money to be worth 75% less instantly on the next raise. Should they be able to get it away